Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax Combined With Azacitidine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755202
What this trial is testing

Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory Leukemia

Who this might be right for
Acute Myeloid LeukemiaAML With FLT3 Mutation
Florian Kuchenbauer 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07486726
What this trial is testing

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)Relapse Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia (AML)
Shanghai Jiao Tong University School of Medicine 112
Early research (Phase 1)Ended earlyNCT02203773
What this trial is testing

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous LeukemiaMyelogenous LeukemiaTreatment Naive AML
AbbVie 212
Early research (Phase 1)Looking for participantsNCT03113643
What this trial is testing

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeBlastic Plasmacytoid Dendritic Cell Neoplasm
Dana-Farber Cancer Institute 72
Early research (Phase 1)Looking for participantsNCT06357182
What this trial is testing

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome/Acute Myeloid Leukemia
OHSU Knight Cancer Institute 30
Post-approval studies (Phase 4)Looking for participantsNCT07044687
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

Who this might be right for
Acute Myeloid Leukemia
AbbVie 100
Testing effectiveness (Phase 2)Looking for participantsNCT05603884
What this trial is testing

VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, AcuteAML Stage, Adult
The First Affiliated Hospital of Xiamen University 66
Early research (Phase 1)Not Yet RecruitingNCT07679334
What this trial is testing

Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05365035
What this trial is testing

A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06014489
What this trial is testing

A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML

Who this might be right for
AML, Adult
Stichting Hemato-Oncologie voor Volwassenen Nederland 142
Testing effectiveness (Phase 2)Ended earlyNCT04550442
What this trial is testing

Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Who this might be right for
Recurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic SyndromeRefractory Chronic Myelomonocytic Leukemia+2 more
M.D. Anderson Cancer Center 34
Not applicableNot Yet RecruitingNCT07632170
What this trial is testing

The Efficacy and Safety of Selinisole Combined With Azacitidine and Venetoclax in the Treatment of Newly Diagnosed High-risk Myeloid Tumors With TP53 Mutations

Who this might be right for
Myeloid Tumors
Bing Han 30
Testing effectiveness (Phase 2)Looking for participantsNCT06220162
What this trial is testing

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 32
Testing effectiveness (Phase 2)Looking for participantsNCT07514832
What this trial is testing

VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial

Who this might be right for
AML (Acute Myeloid Leukemia)
Beijing 302 Hospital 48
Not applicableStudy completedNCT05471700
What this trial is testing

Single Arm Study of Azacitidine and Venetoclax for Treatment of Newly Diagnosed Fit Acute Myeloid Leukemia Patients

Who this might be right for
Leukemia, Myeloid, Acute
Zhujiang Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05566054
What this trial is testing

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

Who this might be right for
Acute Monocytic LeukemiaNewly Diagnosed
The First Affiliated Hospital of Soochow University 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07664839
What this trial is testing

Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations

Who this might be right for
Acute Myeloid LeukemiaNPM1 MutationIDH1 Mutation+1 more
Shen yang 148
Early research (Phase 1)Ended earlyNCT05275439
What this trial is testing

Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Shattuck Labs, Inc. 106
Testing effectiveness (Phase 2)Looking for participantsNCT07425782
What this trial is testing

Venetoclax Combined With Azacitidine for Consolidation Therapy in AML

Who this might be right for
Acute Myeloid LeukemiaConsolidation TherapyVenentoclax+2 more
The First Affiliated Hospital of Soochow University 216
Testing effectiveness (Phase 2)Ended earlyNCT04435691
What this trial is testing

Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 110
Next Page